Global Gastrointestinal Stromal Tumor (GIST) Drug Market Insights and Forecast to 2031

Report ID: 1563962 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Amcasertib
        1.2.3 Anagrelide hydrochloride CR
        1.2.4 APG-1351
        1.2.5 Binimetinib
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
        2.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Gastrointestinal Stromal Tumor (GIST) Drug by Region (2023-2028)
    2.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region
        2.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022)
        2.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers
        3.1.1 Global Top Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug in 2021
    3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers
        3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2021
    3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
        4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type
        4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type
        4.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2022)
        4.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
        5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application
        5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application
        5.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2022)
        5.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
        6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
        6.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
    6.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
        6.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
        6.2.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
    6.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        6.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
        6.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
        7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
        7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
    7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
        7.2.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
        7.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
    7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        7.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
        7.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
        8.1.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
        8.2.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
        8.3.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
        9.1.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
        9.1.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
    9.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
        9.2.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
        9.2.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
    9.3 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        9.3.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
        9.3.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
        10.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
        10.2.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        10.3.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Ariad Pharmaceuticals, Inc.
        11.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
        11.1.2 Ariad Pharmaceuticals, Inc. Overview
        11.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Ariad Pharmaceuticals, Inc. Recent Developments
    11.2 Arog Pharmaceuticals, Inc.
        11.2.1 Arog Pharmaceuticals, Inc. Corporation Information
        11.2.2 Arog Pharmaceuticals, Inc. Overview
        11.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Arog Pharmaceuticals, Inc. Recent Developments
    11.3 Array BioPharma Inc.
        11.3.1 Array BioPharma Inc. Corporation Information
        11.3.2 Array BioPharma Inc. Overview
        11.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Array BioPharma Inc. Recent Developments
    11.4 Astex Pharmaceuticals, Inc.
        11.4.1 Astex Pharmaceuticals, Inc. Corporation Information
        11.4.2 Astex Pharmaceuticals, Inc. Overview
        11.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Astex Pharmaceuticals, Inc. Recent Developments
    11.5 Blueprint Medicines Corporation
        11.5.1 Blueprint Medicines Corporation Corporation Information
        11.5.2 Blueprint Medicines Corporation Overview
        11.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Blueprint Medicines Corporation Recent Developments
    11.6 Boston Biomedical, Inc.
        11.6.1 Boston Biomedical, Inc. Corporation Information
        11.6.2 Boston Biomedical, Inc. Overview
        11.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Boston Biomedical, Inc. Recent Developments
    11.7 Calithera Biosciences, Inc.
        11.7.1 Calithera Biosciences, Inc. Corporation Information
        11.7.2 Calithera Biosciences, Inc. Overview
        11.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Calithera Biosciences, Inc. Recent Developments
    11.8 Chipscreen Biosciences Ltd
        11.8.1 Chipscreen Biosciences Ltd Corporation Information
        11.8.2 Chipscreen Biosciences Ltd Overview
        11.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Chipscreen Biosciences Ltd Recent Developments
    11.9 Deciphera Pharmaceuticals, LLC
        11.9.1 Deciphera Pharmaceuticals, LLC Corporation Information
        11.9.2 Deciphera Pharmaceuticals, LLC Overview
        11.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Deciphera Pharmaceuticals, LLC Recent Developments
    11.10 F. Hoffmann-La Roche Ltd.
        11.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
        11.10.2 F. Hoffmann-La Roche Ltd. Overview
        11.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
    11.11 Horizon Pharma Plc
        11.11.1 Horizon Pharma Plc Corporation Information
        11.11.2 Horizon Pharma Plc Overview
        11.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Horizon Pharma Plc Recent Developments
    11.12 Immunicum AB
        11.12.1 Immunicum AB Corporation Information
        11.12.2 Immunicum AB Overview
        11.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Immunicum AB Recent Developments
    11.13 Jiangsu Hengrui Medicine Co., Ltd.
        11.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
        11.13.2 Jiangsu Hengrui Medicine Co., Ltd. Overview
        11.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
    11.14 Kolltan Pharmaceuticals, Inc.
        11.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information
        11.14.2 Kolltan Pharmaceuticals, Inc. Overview
        11.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments
    11.15 Natco Pharma Limited
        11.15.1 Natco Pharma Limited Corporation Information
        11.15.2 Natco Pharma Limited Overview
        11.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Natco Pharma Limited Recent Developments
    11.16 Nerviano Medical Sciences S.r.l.
        11.16.1 Nerviano Medical Sciences S.r.l. Corporation Information
        11.16.2 Nerviano Medical Sciences S.r.l. Overview
        11.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Nerviano Medical Sciences S.r.l. Recent Developments
    11.17 Novartis AG
        11.17.1 Novartis AG Corporation Information
        11.17.2 Novartis AG Overview
        11.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Novartis AG Recent Developments
    11.18 Omeros Corporation
        11.18.1 Omeros Corporation Corporation Information
        11.18.2 Omeros Corporation Overview
        11.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Omeros Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
    12.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process
    12.4 Gastrointestinal Stromal Tumor (GIST) Drug Sales and Marketing
        12.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels
        12.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
    12.5 Gastrointestinal Stromal Tumor (GIST) Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
    13.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
    13.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
    13.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
14 Key Findings in The Global Gastrointestinal Stromal Tumor (GIST) Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Amcasertib
    Table 3. Major Manufacturers of Anagrelide hydrochloride CR
    Table 4. Major Manufacturers of APG-1351
    Table 5. Major Manufacturers of Binimetinib
    Table 6. Major Manufacturers of Others
    Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
    Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2023-2028)
    Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)
    Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2023-2028)
    Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers (2017-2022)
    Table 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2017-2022)
    Table 21. Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2021)
    Table 24. Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
    Table 26. Date of Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2017-2022)
    Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2023-2028)
    Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2017-2022)
    Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2023-2028)
    Table 36. Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2017-2022)
    Table 41. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2023-2028)
    Table 42. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2017-2022)
    Table 45. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2023-2028)
    Table 46. Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Ariad Pharmaceuticals, Inc. Corporation Information
    Table 109. Ariad Pharmaceuticals, Inc. Description and Major Businesses
    Table 110. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Ariad Pharmaceuticals, Inc. Recent Developments
    Table 113. Arog Pharmaceuticals, Inc. Corporation Information
    Table 114. Arog Pharmaceuticals, Inc. Description and Major Businesses
    Table 115. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Arog Pharmaceuticals, Inc. Recent Developments
    Table 118. Array BioPharma Inc. Corporation Information
    Table 119. Array BioPharma Inc. Description and Major Businesses
    Table 120. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Array BioPharma Inc. Recent Developments
    Table 123. Astex Pharmaceuticals, Inc. Corporation Information
    Table 124. Astex Pharmaceuticals, Inc. Description and Major Businesses
    Table 125. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Astex Pharmaceuticals, Inc. Recent Developments
    Table 128. Blueprint Medicines Corporation Corporation Information
    Table 129. Blueprint Medicines Corporation Description and Major Businesses
    Table 130. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Blueprint Medicines Corporation Recent Developments
    Table 133. Boston Biomedical, Inc. Corporation Information
    Table 134. Boston Biomedical, Inc. Description and Major Businesses
    Table 135. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 136. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Boston Biomedical, Inc. Recent Developments
    Table 138. Calithera Biosciences, Inc. Corporation Information
    Table 139. Calithera Biosciences, Inc. Description and Major Businesses
    Table 140. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 141. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Calithera Biosciences, Inc. Recent Developments
    Table 143. Chipscreen Biosciences Ltd Corporation Information
    Table 144. Chipscreen Biosciences Ltd Description and Major Businesses
    Table 145. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 146. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Chipscreen Biosciences Ltd Recent Developments
    Table 148. Deciphera Pharmaceuticals, LLC Corporation Information
    Table 149. Deciphera Pharmaceuticals, LLC Description and Major Businesses
    Table 150. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 151. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Deciphera Pharmaceuticals, LLC Recent Developments
    Table 153. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 154. F. Hoffmann-La Roche Ltd. Description and Major Businesses
    Table 155. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 156. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 158. Horizon Pharma Plc Corporation Information
    Table 159. Horizon Pharma Plc Description and Major Businesses
    Table 160. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 161. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Horizon Pharma Plc Recent Developments
    Table 163. Immunicum AB Corporation Information
    Table 164. Immunicum AB Description and Major Businesses
    Table 165. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 166. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Immunicum AB Recent Developments
    Table 168. Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
    Table 169. Jiangsu Hengrui Medicine Co., Ltd. Description and Major Businesses
    Table 170. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 171. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
    Table 173. Kolltan Pharmaceuticals, Inc. Corporation Information
    Table 174. Kolltan Pharmaceuticals, Inc. Description and Major Businesses
    Table 175. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 176. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Kolltan Pharmaceuticals, Inc. Recent Developments
    Table 178. Natco Pharma Limited Corporation Information
    Table 179. Natco Pharma Limited Description and Major Businesses
    Table 180. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 181. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Natco Pharma Limited Recent Developments
    Table 183. Nerviano Medical Sciences S.r.l. Corporation Information
    Table 184. Nerviano Medical Sciences S.r.l. Description and Major Businesses
    Table 185. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 186. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Nerviano Medical Sciences S.r.l. Recent Developments
    Table 188. Novartis AG Corporation Information
    Table 189. Novartis AG Description and Major Businesses
    Table 190. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 191. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Novartis AG Recent Developments
    Table 193. Omeros Corporation Corporation Information
    Table 194. Omeros Corporation Description and Major Businesses
    Table 195. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 196. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Omeros Corporation Recent Developments
    Table 198. Key Raw Materials Lists
    Table 199. Raw Materials Key Suppliers Lists
    Table 200. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
    Table 201. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
    Table 202. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
    Table 203. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
    Table 204. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
    Table 205. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
    Table 206. Research Programs/Design for This Report
    Table 207. Key Data Information from Secondary Sources
    Table 208. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Product Picture
    Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2021 & 2028
    Figure 3. Amcasertib Product Picture
    Figure 4. Anagrelide hydrochloride CR Product Picture
    Figure 5. APG-1351 Product Picture
    Figure 6. Binimetinib Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2021 & 2028
    Figure 9. Clinic
    Figure 10. Hospital
    Figure 11. Others
    Figure 12. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
    Figure 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2028 (K Pcs)
    Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 20. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 22. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug in the World: Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2021
    Figure 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    Figure 36. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    Figure 39. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    Figure 40. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country (2017-2028)
    Figure 41. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    Figure 47. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country (2017-2028)
    Figure 49. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Region (2017-2028)
    Figure 61. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Gastrointestinal Stromal Tumor (GIST) Drug Value Chain
    Figure
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Frequently Asked Questions
Gastrointestinal Stromal Tumor (GIST) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Stromal Tumor (GIST) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Stromal Tumor (GIST) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

NADPH Oxidase 4

NADPH Oxidase 4 market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Beta Secretase 1

Beta Secretase 1 market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Hepcidin

Hepcidin market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More

Nociceptin Receptor

Nociceptin Receptor market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More